Pycnogenol delays glucose absorption 190 times more potently than prescription medicationFebruary 08, 2007A new study to be published in an upcoming edition of the journal of Diabetes Research and Clinical Practice reveals that French maritime pine tree extract known as Pycnogenol® (pic-noj-en-all) delays the uptake of glucose from a meal 190 times more than prescription medications, preventing the typical high-glucose peak in the blood stream after a meal. The study revealed the pine bark is more potent for suppressing carbohydrate absorption in diabetes than synthetic prescription alpha-glucosidase inhibitors such as Precose®. "Diabetes mellitus type II is a serious disease with rising prevalence," said Dr. Petra Högger, a lead researcher of this study. "This study is crucial for those suffering with the disease because it affirms that Pycnogenol® is more effective than prescription medication Precose® and supports the abundance of other research done on Pycnogenol® and diabetes." The study was conducted at the University of Wurzburg Germany. Dr. Högger investigated the interaction of Pycnogenol® with the enzyme alpha-glucosidase, which breaks down carbohydrates in a meal. Results revealed Pycnogenol® is 190 times more potent for inhibition of alpha-glucosidase than the synthetic inhibitor acarbose, a common prescription medication for treatment of type II diabetes (sold in Europe under the name Glucobay® and the United States under the name Precose™).
Pycnogenol® was shown to inhibit the intestinal enzymes (alpha-glucosidase) involved in the digestion of complex carbohydrates such as starch and normal table sugar. The alpha-glucosidase breaks down carbohydrates into glucose molecules which are then absorbed into the blood stream. "The high concentration of procyanidins (flavonoids) found in Pycnogenol® is responsible for demonstrating these excellent results," said Högger. According to Högger, the large procyanidin molecules were found to be particularly active for inhibiting the activity of alpha-glucosidase, thus demonstrating such notable results. "The carbohydrates enter the blood stream steadily over prolonged periods of time, which make meals last longer and prolong satiety." In two separate studies conducted in 2004, Pycnogenol® was found to significantly lower blood sugar levels in type II diabetes patients. A study published in the March 2004 edition of Diabetes Care revealed that patients who supplemented with Pycnogenol® experienced lower blood sugar after meals and lower fasting blood sugar. Another study published in the October edition of Life Sciences revealed a significantly further lowered blood glucose level in patients who supplemented with Pycnogenol® while continuing their anti-diabetic medication with acarbose and metformin. This study opens new avenues for product development of Pycnogenol® in the field of diabetes, metabolic syndrome and obesity. "With seven percent of Americans diagnosed with diabetes, more than one in five people afflicted with metabolic syndrome, and 60 million U.S. adults considered obese, finding natural and safe options for managing these conditions and improving quality of life is a priority," said Högger. About Pycnogenol® Pycnogenol® is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and organic acids, which offer extensive natural health benefits. The extract has been widely studied for the past 35 years and has more than 220 published studies and review articles ensuring safety and efficacy as an ingredient. Today, Pycnogenol® is available in more than 600 dietary supplements, multi-vitamins and health products worldwide. For more information, visit www.pycnogenol.com. MWW Group | |||||||||||||||||||||
|
Related Glucose News Articles Risks and benefits of antipsychotics in children and adolescents Many of the psychiatric disorders observed in adults have their onset in childhood or adolescence. In fact some studies show that at least 20% of children and adolescents will fulfil a diagnostic criterion for a mental disorder before reaching adulthood. Findings challenge common practice regarding glucose control for critically ill patients An analysis of randomized trials indicates that for critically ill adults, tight glucose control is not associated with a significantly reduced risk of death in the hospital, but is associated with an increased risk of hypoglycemia, calling into question the recommendation by many professional societies for tight glucose control for these patients. Scientists discover leptin can also aid type 1 diabetics Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by scientists at UT Southwestern Medical Center. Seeing through tooth decay Dental caries afflict at least 90% of the world's population at some time in their lives. Detecting the first signs of this disease, which can be lethal in extreme cases, just got easier thanks to work by researchers in India discussed in the latest issue of the International Journal of Biomedical Engineering and Technology. Study shows that surgical weight loss does not eliminate obstructive sleep apnea A study in the August 15 issue of the Journal of Clinical Sleep Medicine shows that surgical weight loss results in an improvement of obstructive sleep apnea (OSA), but most patients continue to have moderate to severe OSA one year after undergoing bariatric surgery. Overweight Hispanic children at significant risk for pre-diabetes, according to new USC study A study by researchers at the University of Southern California (USC) found that overweight Hispanic children are at significant risk for pre-diabetes, a condition marked by higher than normal blood glucose levels that are not yet high enough for a diagnosis of diabetes. Cognitive problems associated with diabetes duration and severity Individuals with mild cognitive impairment appear more likely to have earlier onset, longer duration and greater severity of diabetes, according to a report in the August issue of Archives of Neurology, one of the JAMA/Archives journals. Losing weight soon after type 2 diabetes diagnosis doubles positive outcomes People who lose weight soon after a diagnosis of type 2 diabetes have better control of their blood pressure and blood sugar, and are more likely to maintain that control even if they regain their weight, according to a Kaiser Permanente study published online in Diabetes Care, the American Diabetes Association journal. Improved reaction data heat up the biofuels harvest High food prices, concern over dwindling supplies of fossil fuels and the desire for clean, renewable energy have led many to seek ways to make ethanol out of cellulosic sources such as wood, hay and switchgrass. Estrogen relieves psychotic symptoms in women with schizophrenia When combined with antipsychotic medications, the estrogen estradiol appears to be a useful treatment in women with schizophrenia, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. More Glucose News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||